{
    "clinical_study": {
        "@rank": "109119", 
        "acronym": "PARBO", 
        "arm_group": {
            "arm_group_label": "Bosentan", 
            "arm_group_type": "Experimental", 
            "description": "62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months"
        }, 
        "brief_summary": {
            "textblock": "6 months therapy of Bosentan, an endothelin antagonist, will lead to improvement in\n      pulmonary microvascular endothelial function."
        }, 
        "brief_title": "Bosentan and Pulmonary Endothelial Function", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "62.5 mg Bosentan b.i.d. for 1 month 125 mg Bosentan b.i.d. for 5 months", 
                        "title": "Bosentan"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "8"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "4", 
                                            "@value": "66"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "8"
                                        }
                                    }, 
                                    "sub_title": "Australia"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Percent pulmonary flow change from baseline after acetylcholine", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months", 
                                "title": "Bosentan"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "8"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "20", 
                                                    "@value": "180"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Percent pulmonary flow change from baseline after acetylcholine", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Acetylcholine Vascular Reactivity Response", 
                                    "units": "percentage of baseline"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and 6 months", 
                        "title": "Acetylcholine Vascular Reactivity Response", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Change in intima-media thickness", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months", 
                                "title": "Bosentan"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "8"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2", 
                                                    "@value": "34"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Change in intima-media thickness", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Intravascular Ultrasound - Pulmonary Artery Wall Thickness", 
                                    "units": "percentage of baseline"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "baseline and 6 months", 
                        "title": "Intravascular Ultrasound - Pulmonary Artery Wall Thickness", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months", 
                        "title": "Bosentan"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "8", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "8", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "david.celermajer@email.cs.nsw.gov.au", 
                "name_or_title": "Prof David Celermajer", 
                "organization": "Royal Prince Alfred Hospital, Sydney, Australia", 
                "phone": "+61 2 9515 6519"
            }
        }, 
        "completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "condition": "Pulmonary Arterial Hypertension", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension, Pulmonary", 
                "Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pulmonary arterial hypertension; idiopathic and connective tissue disease associated\n\n          -  Confirmed or invasive haemodynamic:\n\n          -  Mean pulmonary arterial pressure greater than or equal to 25 millimeters of mercury\n\n          -  Pulmonary capillary wedge pressure less than 15 millimeters of mercury\n\n          -  No prior pulmonary hypertension specific therapy\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Contra-indications to medications used to test endothelial function; acetylcholine,\n             sodium nitroprusside, NG-Monomethyl-L-Arginine, L-arginine\n\n          -  Advanced renal disease\n\n          -  Previous allergic reaction to contrast agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 2012", 
        "firstreceived_results_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01721564", 
            "org_study_id": "NCT00595049"
        }, 
        "intervention": {
            "arm_group_label": "Bosentan", 
            "description": "62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months", 
            "intervention_name": "Bosentan", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Bosentan"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 21, 2013", 
        "number_of_arms": "1", 
        "official_title": "Pulmonary Artery Remodelling With Bosentan", 
        "overall_official": {
            "affiliation": "Royal Prince Alfred Hospital, Sydney, Australia", 
            "last_name": "David S Celermajer, MBBS, PhD, DSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Australia: Department of Health and Ageing Therapeutic Goods Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Percent pulmonary flow change from baseline after acetylcholine", 
            "measure": "Acetylcholine Vascular Reactivity Response", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01721564"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Royal Prince Alfred Hospital, Sydney, Australia", 
            "investigator_full_name": "Prof David S Celermajer", 
            "investigator_title": "Scandrett Professor of Cardiology", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Change in intima-media thickness", 
            "measure": "Intravascular Ultrasound - Pulmonary Artery Wall Thickness", 
            "safety_issue": "No", 
            "time_frame": "baseline and 6 months"
        }, 
        "source": "Royal Prince Alfred Hospital, Sydney, Australia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Prof David S Celermajer", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2006", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}